Glucagon‐like Peptide‐2 (GLP‐2) Response to Enteral Intake in Children During Anti‐Cancer Treatment
Bente Utoft Andreassen(University of Copenhagen), Kim F. Michaelsen(University of Copenhagen), Bolette Hartmann(University of Copenhagen), Anders Pærregaard(Amager Hospital), Kjeld Schmiegelow(University of Copenhagen), Carsten Heilman(Rigshospitalet), Jens J. Holst(University of Copenhagen), Catherine Rechnitzer(University of Copenhagen)
Journal of Pediatric Gastroenterology and Nutrition
January 1, 2005
Cited by 1
Related Papers
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Screening of Probiotic Activities of Forty-Seven Strains of <i>Lactobacillus</i> spp. by In Vitro Techniques and Evaluation of the Colonization Ability of Five Selected Strains in Humans
|Applied and Environmental Microbiology|1999|868
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724